STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD)
Clinical trials for STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD) explained in plain language.
Never miss a new study
Get alerted when new STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD) trials appear
Sign up with your email to follow new studies for STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lab-Grown cells offer hope for transplant complication
Disease control Recruiting nowThis study tests a new treatment made from special lab-grown cells (iMSC) for people with a severe complication after bone marrow transplant called graft-versus-host disease that does not respond to steroids. The goal is to see if the treatment is safe and if it can help control …
Matched conditions: STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD)
Phase: NA • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated May 17, 2026 05:08 UTC
-
Desperate patients gain access to promising drug through managed programs
Disease control AVAILABLEThis program provides access to the drug ruxolitinib (INC424) for patients with serious or life-threatening conditions like certain blood cancers, severe COVID-19, or graft-versus-host disease when no other treatments are available. It is for people who cannot join a clinical tri…
Matched conditions: STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE(SR-AGVHD)
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:55 UTC